Westfield Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7M | Buy |
|
|||||
|
2025
Q1 | $32.8M | Sell |
|
|||||
|
2024
Q4 | $86.9M | Buy |
|
|||||
|
2024
Q3 | $84.6M | Buy |
|
|||||
|
2024
Q2 | $66.4M | Buy |
|
|||||
|
2024
Q1 | $79.7M | Sell |
|
|||||
|
2023
Q4 | $79.8M | Sell |
|
|||||
|
2023
Q3 | $130M | Sell |
|
|||||
|
2023
Q2 | $153M | Buy |
|
|||||
|
2023
Q1 | $185M | Sell |
|
|||||
|
2022
Q4 | $164M | Buy |
|
|||||
|
2022
Q3 | $151M | Buy |
|
|||||
|
2022
Q2 | $178M | Buy |
|
|||||
|
2022
Q1 | $193M | Buy |
|
|||||
|
2021
Q4 | $251M | Sell |
|
|||||
|
2021
Q3 | $261M | Sell |
|
|||||
|
2021
Q2 | $262M | Buy |
|
|||||
|
2021
Q1 | $231M | Sell |
|
|||||
|
2020
Q4 | $240M | Buy |
|
|||||
|
2020
Q3 | $154M | Sell |
|
|||||
|
2020
Q2 | $160M | Sell |
|
|||||
|
2020
Q1 | $137M | Sell |
|
|||||
|
2019
Q4 | $170M | Buy |
|
|||||
|
2019
Q3 | $137M | Buy |
|
|||||
|
2019
Q2 | $112M | Sell |
|
|||||
|
2019
Q1 | $115M | Buy |
|
|||||
|
2018
Q4 | $87.3M | Buy |
|
|||||
|
2018
Q3 | $109M | Buy |
|
|||||
|
2018
Q2 | $75.5M | Buy |
|
|||||
|
2018
Q1 | $62.1M | Buy |
|
|||||
|
2017
Q4 | $35.6M | Buy |
|
|||||
|
2017
Q3 | $22.2M | Buy |
|